Circulating platelet-derived vesicle in atrial fibrillation
Annals of Clinical Hypertension · 2019
DOI: 10.29328/journal.ach.1001016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Clinical Hypertension, 2019. Verfasst von Alexander E Berezin und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Platelet vesiculation is common factor contributing in coagulation and thromboembolism in patients with atrial fibrillation (AF). Platelet-derived vesicles are involved in the coagulation, thromboembolism, microvascular inflammation, arterial stiffness, vascular calcification, atherosclerotic plaque shaping and rupture, endothelial dysfunction, cardiac remodelling, and kidney dysfunction. Recent clinical studies have revealed elevated concentrations of platelet-derived vesicles in peripheral blood of patients with current AF and history of AF. The aim of the mini review is to discuss the role of platelet-derived micro vesicles as predictive biomarker in AF. Serial measures of circulating levels of platelet-derived vesicules are discussed to be useful in stratification of AF patients at risk of thromboembolic complications, but there is limiting evidence regarding their predictive value that requires further investigations in large clinical trials.
Zitieren
APA
Berezin, A. E., & Berezin, A. A. (2019). Circulating platelet-derived vesicle in atrial fibrillation. Annals of Clinical Hypertension. https://doi.org/10.29328/journal.ach.1001016
Vancouver
Berezin AE, Berezin AA. Circulating platelet-derived vesicle in atrial fibrillation. Annals of Clinical Hypertension. 2019. doi:10.29328/journal.ach.1001016
BibTeX
@article{Berezin2019,
author = {Berezin, Alexander E and Berezin, Alexander A},
title = {Circulating platelet-derived vesicle in atrial fibrillation},
journal = {Annals of Clinical Hypertension},
year = {2019},
doi = {10.29328/journal.ach.1001016}
}
EUVIMED